Benjamin F. Edwards & Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $559K | Sell |
4,075
-3,167
| -44% | -$423K | 0.01% | 663 |
|
|
2024
Q1 | $994K | Buy |
7,242
+3,757
| +108% | +$513K | 0.02% | 513 |
|
|
2023
Q4 | $473K | Sell |
3,485
-71
| -2% | -$8.66K | 0.01% | 645 |
|
|
2023
Q3 | $435K | Sell |
3,556
-213
| -6% | -$27.1K | 0.02% | 557 |
|
|
2023
Q2 | $479K | Sell |
3,769
-1,377
| -27% | -$179K | 0.02% | 523 |
|
|
2023
Q1 | $665K | Sell |
5,146
-168
| -3% | -$22K | 0.03% | 421 |
|
|
2022
Q4 | $698K | Sell |
5,314
-1,212
| -19% | -$157K | 0.03% | 394 |
|
|
2022
Q3 | $763K | Buy |
6,526
+485
| +8% | +$60.2K | 0.04% | 361 |
|
|
2022
Q2 | $711K | Buy |
6,041
+222
| +4% | +$26.4K | 0.03% | 392 |
|
|
2022
Q1 | $758K | Sell |
5,819
-7,286
| -56% | -$949K | 0.03% | 389 |
|
|
2021
Q4 | $2M | Buy |
13,105
+933
| +8% | +$144K | 0.09% | 221 |
|
|
2021
Q3 | $1.97M | Sell |
12,172
-475
| -4% | -$79.9K | 0.1% | 209 |
|
|
2021
Q2 | $2.07M | Sell |
12,647
-82
| -0.6% | -$12.6K | 0.11% | 208 |
|
|
2021
Q1 | $1.92M | Buy |
12,729
+199
| +2% | +$31.6K | 0.1% | 213 |
|
|
2020
Q4 | $1.9M | Sell |
12,530
-887
| -7% | -$127K | 0.11% | 198 |
|
|
2020
Q3 | $1.82M | Sell |
13,417
-1,622
| -11% | -$220K | 0.12% | 187 |
|
|
2020
Q2 | $2.06M | Buy |
15,039
+3,327
| +28% | +$424K | 0.15% | 160 |
|
|
2020
Q1 | $1.26M | Buy |
11,712
+843
| +8% | +$97.1K | 0.11% | 196 |
|
|
2019
Q4 | $1.31M | Buy |
10,869
+1,892
| +21% | +$211K | 0.09% | 223 |
|
|
2019
Q3 | $893K | Buy |
8,977
+1,301
| +17% | +$136K | 0.07% | 275 |
|
|
2019
Q2 | $837K | Buy |
7,676
+2,745
| +56% | +$292K | 0.07% | 269 |
|
|
2019
Q1 | $551K | Buy |
4,931
+3,566
| +261% | +$391K | 0.05% | 317 |
|
|
2018
Q4 | $132K | Buy |
1,365
+474
| +53% | +$50.3K | 0.01% | 582 |
|
|
2018
Q3 | $109K | Buy |
891
+770
| +636% | +$90.7K | 0.01% | 651 |
|
|
2018
Q2 | $13K | Sell |
121
-30
| -20% | -$3.21K | ﹤0.01% | 1202 |
|
|
2018
Q1 | $16K | Buy |
151
+10
| +7% | +$1.11K | ﹤0.01% | 1139 |
|
|
2017
Q4 | $15K | Sell |
141
-417
| -75% | -$44.6K | ﹤0.01% | 1095 |
|
|
2017
Q3 | $62K | Buy |
558
+537
| +2,557% | +$57.4K | 0.01% | 719 |
|
|
2017
Q2 | $2K | Hold |
21
| – | – | ﹤0.01% | 1374 |
|
|
2017
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 1278 |
|
|
2016
Q4 | $2K | Sell |
21
-27
| -56% | -$2.46K | ﹤0.01% | 1162 |
|
|
2016
Q3 | $5K | Buy |
+48
| New | +$4.57K | ﹤0.01% | 950 |
|
|
2014
Q4 | – | Sell |
-195
| Closed | -$18K | – | 1031 |
|
|
2014
Q3 | $18K | Hold |
195
| – | – | ﹤0.01% | 671 |
|
|
2014
Q2 | $17K | Sell |
195
-360
| -65% | -$28.4K | ﹤0.01% | 648 |
|
|
2014
Q1 | $44K | Hold |
555
| – | – | 0.01% | 464 |
|
|
2013
Q4 | $42K | Hold |
555
| – | – | 0.01% | 454 |
|
|
2013
Q3 | $39K | Hold |
555
| – | – | 0.01% | 432 |
|
|
2013
Q2 | $32K | Buy |
+555
| New | +$32.1K | 0.01% | 413 |
|
Other funds holding IBB
CB
Benjamin F. Edwards & Company's IBB Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its iShares Biotechnology ETF (IBB) stake by 44% in Q2 2024, selling an estimated $423K and leaving 4,075 shares worth $559K. The position accounts for 0.01% of the portfolio, ranked #663.
Benjamin F. Edwards & Company first reported a position in IBB in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.07M in Q2 2021. 896 funds tracked by Wall St. Rank hold IBB as of Q2 2024.
- Benjamin F. Edwards & Company held 4,075 shares of iShares Biotechnology ETF worth $559K as of Q2 2024.
- Benjamin F. Edwards & Company sold 3,167 iShares Biotechnology ETF shares in Q2 2024, an estimated $423K.
- iShares Biotechnology ETF made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #663 holding.
- Benjamin F. Edwards & Company first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 38 quarters since.
- Benjamin F. Edwards & Company's iShares Biotechnology ETF position peaked at $2.07M in Q2 2021.
- 896 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.